The basic report “Cannabis Prescription Study 2020” is now available on request – with extensive information from more than 10,000 telephone interviews with medical specialists.
These were systematically processed within the scope of the study and can be used as a basis for strategic corporate decisions.
This whitepaper includes the following contents:
- objectives and use of the “Cannabis Prescription Study 2020”
- profile and contents of the basic report “Cannabis Prescription Study 2020”
- possibilities of acquiring more detailed special analyses to supplement the basic report
- excerpts from the “Cannabis Prescription Study 2020”
Request now the WHITEPAPER for FREE per mail:
timm.harder@the-lifesights-company.com